Oregon vs Washington Cannabis Laws

Oregon was among the earliest states to legalize recreational cannabis, with voters approving Measure 91 in November 2014. Retail sales began in October 2015. The state's medical program dates back to 1998 through the Oregon Medical Marijuana Act, giving Oregon one of the longest histories with legal cannabis in the country.

The Oregon market has been both a success story and a cautionary tale. The state's open licensing approach and favorable growing climate led to massive oversupply, driving wholesale flower prices below $500 per pound at their lowest. Annual sales have stabilized around $1 billion, but many operators have struggled with thin or negative margins. Oregon's experience has heavily influenced policy discussions in other states about the importance of supply management.

Curaleaf and Cresco Labs maintain Oregon operations, but the market is dominated by local operators, including a vibrant craft cannabis segment. Oregon's 17% retail tax plus up to 3% local tax creates a combined rate of up to 20%. The state continues to advocate for interstate cannabis commerce, which could allow Oregon's surplus production to reach consumers in other states, but federal legalization would be required for such a framework to develop.

Washington State, alongside Colorado, was a pioneer in cannabis legalization. Initiative 502 was approved by voters in November 2012, and the first recreational retail stores opened in July 2014. The state's medical cannabis program dates back to 1998, making Washington one of the earliest states to embrace legal cannabis in any form.

The Washington market generates over $1.5 billion in annual sales and features a mature regulatory framework. Notably, the state prohibits vertical integration — producer/processor licenses and retail licenses must be held by separate entities. This structure was designed to prevent monopolistic behavior and promote competition at each level of the supply chain. A moratorium on new retail licenses has been in place for several years, limiting retail expansion.

Washington's 37% excise tax on recreational cannabis is one of the highest in the nation, yet the market has remained robust due to strong consumer demand in the Seattle metropolitan area and statewide. Despite the market's size, most major MSOs have limited Washington exposure, with Cresco Labs being the most notable operator. The prohibition on vertical integration and high tax rate have made Washington less attractive for MSOs compared to states with more favorable regulatory structures. The market remains dominated by local operators.